Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with...

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Genetic Basis of Heart Disease

Background:

• Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are often linked to mutations in sarcomeric proteins.
• Cardiac actin (ACTC) and cardiac myosin binding protein-C (cMyBP-C) are key sarcomere components known to interact.
• Numerous ACTC variants have been identified in patients with HCM or DCM, suggesting a role in disease pathogenesis.

Purpose of the Study:

• To investigate whether identified ACTC variants alter the interaction with cMyBP-C.
• To test the hypothesis that ACTC variants disrupt protein-protein interactions within the sarcomere.
• To elucidate potential mechanisms linking ACTC mutations to cardiomyopathies.

Main Methods:

• Examined interactions between seven ACTC variants and the N-terminal C0C2 fragment of cMyBP-C.
• Utilized binding affinity assays to quantify the strength of protein-protein interactions.
• Measured dissociation constants (Kd values) to assess binding changes.

Main Results:

• A significant decrease in binding affinity was observed for two ACTC variants: A331P and Y166C.
• These variants exhibited increased Kd values, indicating weaker binding to cMyBP-C.
• The findings suggest altered interactions between specific ACTC variants and cMyBP-C.

Conclusions:

• Reduced binding affinity between certain ACTC variants and cMyBP-C may contribute to the development of hypertrophic or dilated cardiomyopathies.
• These results provide a molecular basis for understanding how ACTC mutations lead to heart muscle disease.
• The study also offers insights into the binding site of the cMyBP-C C0C2 fragment on F-actin.